Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world. Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry and a leading position in the submission of generic product applications globally. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
Dublin, IE
30,000 (est)
Allergan was founded in 1948 and is headquartered in Dublin, IE

Allergan Locations

Dublin, IE
Parsippany-Troy Hills, US
Weston, US

Allergan Metrics

Allergan Summary

Market capitalization

$80.6 B

Closing share price

Allergan's current market capitalization is $80.6 B.

Allergan Market Value History

Allergan Online Presence

Allergan News

Allergan Company Life

You may also be interested in